Evidence map›Paper›PMID 42602275›Full record

ArticleBiomaterials research2026

A Degradable Nanoplatform Integrating Glucose Oxidase and Copper Selenide for Near-Infrared-Enhanced Multimodal Synergistic Therapy in Lung Cancer.

Yong Zhang, Lei Xue, Lin Shi, Mengni Zhu, Jun Li, Degang Liu, Qiang Yang, Jiebai Zhou, Zilong Liu, Dawei Yang and 1 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Biomaterials research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Yong ZhangDepartment of Pulmonary, Zhongshan Hospital, Fudan University, Shanghai 200032, China.ORCID https://orcid.org/0000-0003-1631-7048
Lei XueDepartment of Thoracic Surgery, The Third Affiliated Hospital of Southern Medical University, Guangzhou 510630, China.
Lin ShiDepartment of Pulmonary, Zhongshan Hospital, Fudan University, Shanghai 200032, China.
Mengni ZhuShanghai Key Laboratory of Magnetic Resonance, School of Physics and Electronic Science, East China Normal University, Shanghai 200241, China.
Jun LiDepartment of Thoracic Surgery, The Third Affiliated Hospital of Southern Medical University, Guangzhou 510630, China.
Degang LiuDepartment of Thoracic Surgery, The Third Affiliated Hospital of Southern Medical University, Guangzhou 510630, China.
Qiang YangDepartment of Thoracic Surgery, The Third Affiliated Hospital of Southern Medical University, Guangzhou 510630, China.
Jiebai ZhouDepartment of Pulmonary, Zhongshan Hospital, Fudan University, Shanghai 200032, China.
Zilong LiuDepartment of Pulmonary, Zhongshan Hospital, Fudan University, Shanghai 200032, China.
Dawei YangDepartment of Pulmonary, Zhongshan Hospital, Fudan University, Shanghai 200032, China.
Jiangzhou PengDepartment of Thoracic Surgery, The Third Affiliated Hospital of Southern Medical University, Guangzhou 510630, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Lung cancer remains a leading cause of cancer-related mortality worldwide, with therapeutic outcomes frequently constrained by drug resistance, tumor heterogeneity, and systemic toxicity. Multimodal synergistic therapy has emerged as a promising strategy to address these challenges. In this study, we developed a biodegradable nanosystem, designated CSZG, which integrates glucose oxidase (GOx) and copper-rich copper selenide (Cu

Identifiers

PMID42602275
PMCPMC13473715

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.